clorazepate dipotassium has been researched along with Cardiovascular Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wheatley, D | 1 |
| Bentel, HU; Schoenemeyer, J | 1 |
1 trial(s) available for clorazepate dipotassium and Cardiovascular Diseases
| Article | Year |
|---|---|
Psychological stress and cardiovascular diseases.
Topics: Anti-Anxiety Agents; Bendroflumethiazide; Cardiovascular Diseases; Clinical Trials as Topic; Clorazepate Dipotassium; Humans; Hypertension; Medazepam; Methyldopa; Propranolol; Stress, Psychological | 1984 |
1 other study(ies) available for clorazepate dipotassium and Cardiovascular Diseases
| Article | Year |
|---|---|
[Treatment of general psychovegetative disorders with a single night dose of dipotassium-clorazepate within a multicenter study (author's transl)].
Topics: Anti-Anxiety Agents; Antidepressive Agents; Anxiety; Cardiovascular Diseases; Clorazepate Dipotassium; Drug Administration Schedule; Drug Evaluation; Gastrointestinal Diseases; Humans; Psychophysiologic Disorders; Skin Manifestations; Sleep Initiation and Maintenance Disorders | 1978 |